Talkspace, Inc. Income Taxes Disclosure
NOTE 12. INCOME TAXES
In December 2023, the FASB issued a new accounting standard which includes new and updated income tax disclosures, including disaggregation of information in the rate reconciliation and income taxes paid, which we adopted on a prospective basis for the year ended December 31, 2025.
A reconciliation of the statutory federal income tax rate to the Company's effective income tax rate for the year ended December 31, 2025 is as follows:
|
|
Year Ended December 31, 2025 |
|
|||||
(in thousands, except percentages) |
|
Amount |
|
|
% |
|
||
U.S. Federal Statutory Tax Rate |
|
$ |
1,757 |
|
|
|
21.0 |
% |
State and local income taxes, net of federal income tax effect (1) |
|
|
(439 |
) |
|
|
(5.2 |
)% |
Foreign tax effects: |
|
|
|
|
|
|
||
Statutory tax rate difference between Israel and U.S. |
|
|
(8 |
) |
|
|
(0.1 |
)% |
Effects of cross-border tax laws: |
|
|
|
|
|
|
||
Global intangible low-taxed income |
|
|
400 |
|
|
|
4.8 |
% |
Changes in valuation allowance |
|
|
(1,351 |
) |
|
|
(16.1 |
)% |
Nontaxable or nondeductible items: |
|
|
|
|
|
|
||
Stock-based compensation |
|
|
(317 |
) |
|
|
(3.8 |
)% |
IRC Section 162M limitation |
|
|
189 |
|
|
|
2.3 |
% |
Other |
|
|
42 |
|
|
|
0.5 |
% |
Other adjustments: |
|
|
|
|
|
|
||
Reduction in NOL carry-forwards (Section 382 limitation) |
|
|
301 |
|
|
|
3.6 |
% |
Income tax expense |
|
$ |
574 |
|
|
|
6.9 |
% |
A reconciliation of the statutory federal income tax rate to the Company's effective income tax rate for the year ended December 31, 2024 and 2023 is as follows:
|
|
Year Ended December 31, |
|
|||||
(in thousands, except percentages) |
|
2024 |
|
|
2023 |
|
||
Income (loss) before income tax |
|
$ |
1,242 |
|
|
$ |
(18,964 |
) |
Statutory tax rate |
|
|
21 |
% |
|
|
21 |
% |
Federal taxes |
|
|
261 |
|
|
|
(3,982 |
) |
Increase (decrease) in effective tax rate due to: |
|
|
|
|
|
|
||
State taxes, net of federal effect |
|
|
(164 |
) |
|
|
276 |
|
Permanent differences |
|
|
683 |
|
|
|
897 |
|
Other adjustments |
|
|
(648 |
) |
|
|
(373 |
) |
Valuation allowance |
|
|
(38 |
) |
|
|
3,400 |
|
Income tax expense |
|
$ |
94 |
|
|
$ |
218 |
|
The main reconciling item between the statutory tax rate and the effective tax rate for the year ended December 31, 2025 is the change in valuation allowance which was impacted by higher net income during the year ended December 31, 2025 and the enactment of the OBBBA in July 2025, which altered the treatment of unamortized Section 174 expenses and impacted the projected realization of deferred tax assets.
Income (loss) before income taxes is attributable to the following tax jurisdictions:
|
|
Year Ended December 31, |
|
|||||||||
(in thousands) |
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
U.S. |
|
$ |
8,200 |
|
|
$ |
1,078 |
|
|
$ |
(19,576 |
) |
Foreign |
|
|
167 |
|
|
|
164 |
|
|
|
612 |
|
Income (loss) before income tax |
|
$ |
8,367 |
|
|
$ |
1,242 |
|
|
$ |
(18,964 |
) |
Income tax expense applicable to income (loss) before income taxes consists of the following:
|
|
Year Ended December 31, |
|
|||||||||
(in thousands) |
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Current income taxes: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
State |
|
|
468 |
|
|
|
169 |
|
|
|
44 |
|
Foreign |
|
|
106 |
|
|
|
46 |
|
|
|
174 |
|
Total current |
|
|
574 |
|
|
|
215 |
|
|
|
218 |
|
Deferred income taxes: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
|
— |
|
|
|
— |
|
|
|
— |
|
State |
|
|
— |
|
|
|
(121 |
) |
|
|
— |
|
Foreign |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total deferred |
|
|
— |
|
|
|
(121 |
) |
|
|
— |
|
Income tax expense |
|
$ |
574 |
|
|
$ |
94 |
|
|
$ |
218 |
|
The amount of cash paid for income taxes (net of refunds) for the year ended December 31, 2025 is as follows:
|
|
Year Ended December 31, 2025 |
|
|
(in thousands) |
|
|
|
|
Federal |
|
$ |
— |
|
State |
|
|
|
|
Texas |
|
|
57 |
|
Pennsylvania |
|
|
30 |
|
Maryland |
|
|
30 |
|
Tennessee |
|
|
23 |
|
Other |
|
|
81 |
|
Foreign |
|
|
|
|
Israel |
|
|
196 |
|
Total income taxes paid, net of refunds |
|
$ |
417 |
|
For the years ended December 31, 2024 and 2023, we paid $0.1 million and $0.2 million, respectively, in income taxes, net of refunds received.
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:
|
|
As of |
|
|||||
(in thousands) |
|
2025 |
|
|
2024 |
|
||
Net deferred tax assets: |
|
|
|
|
|
|
||
Net operating loss carryforwards |
|
$ |
72,523 |
|
|
$ |
70,373 |
|
Stock based compensation |
|
|
3,282 |
|
|
|
3,338 |
|
Lease liability |
|
|
125 |
|
|
|
164 |
|
Depreciation and amortization |
|
|
44 |
|
|
|
232 |
|
Other |
|
|
91 |
|
|
|
37 |
|
Total gross deferred tax assets |
|
|
76,065 |
|
|
|
74,144 |
|
Valuation allowance |
|
|
(72,627 |
) |
|
|
(73,978 |
) |
Deferred tax liabilities: |
|
|
|
|
|
|
||
Section 174 |
|
|
(3,312 |
) |
|
|
— |
|
Right-of-use asset |
|
|
(126 |
) |
|
|
(166 |
) |
Net deferred tax assets |
|
$ |
— |
|
|
$ |
— |
|
Realization of the future tax benefits is dependent on the Company’s ability to generate sufficient taxable income within the carryforward period. A valuation allowance is provided for deferred tax assets when it is “more likely than not” that some portion of the deferred tax asset will not be realized. Because of the Company’s history of operating losses, management believes the recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not more likely than not to be realized and, accordingly, has provided a full valuation allowance. A valuation allowance has been recorded for the deferred tax assets at December 31, 2025 and 2024.
The Company maintains a full valuation allowance on its net deferred tax assets. The assessment regarding whether a valuation allowance is required considers both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. In making this assessment, significant weight is given to evidence that can be objectively verified. Management considered the Company’s cumulative loss in recent years as significant negative evidence. Based upon a review of the four sources of income identified within ASC 740, management determined that the negative evidence outweighed the positive evidence and that a full valuation allowance on the net deferred tax assets will be maintained. Management will continue to assess the realizability of our deferred tax assets going forward and will adjust the valuation allowance as needed. The valuation allowance decreased approximately $1.4 million for the year ended December 31, 2025. This change was primarily driven by the enactment of the OBBBA in July 2025, which altered the treatment of unamortized Section 174 expenses and impacted the projected realization of deferred tax assets.
At December 31, 2025, the Company has federal and state net operating loss carryovers (“NOL”) of approximately $283.2 million and $210.4 million, respectively, which are available to reduce future taxable income. The NOL carryforwards begin to expire in 2035 and may become subject to annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50%, as defined under I.R.C. Section 382. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or future tax liabilities. The federal losses generated from 2018 onward do not expire.
The Company is subject to U.S. federal and state and Israeli income taxes with varying statutes of limitations. The Company is no longer subject to U.S. federal, state or local income tax examinations by the tax authorities for years before 2022. The Israel subsidiary tax filings filed by the Company through the year 2020 are considered closed.
In July 2025, the OBBBA was enacted, introducing amendments to the U.S. federal income tax code. The OBBBA permanently restores 100% bonus depreciation for qualified property acquired and placed in service after January 19, 2025, and allows immediate expensing of domestic research and experimental expenditures for tax years beginning after December 31, 2024. Certain provisions are effective for fiscal 2025 and are recognized in the consolidated financial statements for the year ended December 31, 2025. Certain other provisions are effective in future fiscal years. Although we continue to maintain a full valuation allowance against our U.S. deferred tax assets as of December 31, 2025, we expect these provisions to increase available deductions and extend the period during which future taxable income may be sheltered, improving liquidity to the extent we generate taxable income.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 13, 2026 | Showing above |
| 2024 | Mar 12, 2025 | |
| 2023 | Mar 13, 2024 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Mar 29, 2021 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.